BCL2 and acute lymphoblastic leukemia: We identified that functional BCL-2 dependence of apoptosis signaling in ALL cells was the best marker associated with VEN response analyzed in isolated ALL cells ex vivo and, importantly, predicted VEN activity in a preclinical in vivo trial in xenografted mice.